TOURMALINE BIO INC (TRML) Stock Analyst Ratings
NASDAQ:TRML - Nasdaq - US89157D1054 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 86% to TRML. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 53.91. This target is 236.75% above the current price.
TRML was analyzed by 16 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about TRML.
In the previous month the buy percentage consensus was at a similar level.
TRML was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-03-14 | Wedbush | Maintains | Outperform -> Outperform |
| 2025-03-14 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-03-06 | Wedbush | Initiate | Outperform |
| 2025-02-24 | LifeSci Capital | Initiate | Outperform |
| 2024-12-11 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-12-11 | Guggenheim | Reiterate | Buy -> Buy |
| 2024-12-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-06 | BMO Capital | Initiate | Outperform |
| 2024-11-11 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-08-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-25 | Truist Securities | Reiterate | Buy -> Buy |
| 2024-03-20 | Jefferies | Maintains | Buy -> Buy |
| 2024-03-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-12-15 | Jefferies | Initiate | Buy |
| 2023-11-17 | Truist Securities | Initiate | Buy |
| 2023-10-31 | Guggenheim | Initiate | Buy |
| 2023-10-25 | Piper Sandler | Initiate | Overweight |